GB0328796D0 - Compounds which interact with the G-protein coupled receptor family - Google Patents
Compounds which interact with the G-protein coupled receptor familyInfo
- Publication number
- GB0328796D0 GB0328796D0 GBGB0328796.8A GB0328796A GB0328796D0 GB 0328796 D0 GB0328796 D0 GB 0328796D0 GB 0328796 A GB0328796 A GB 0328796A GB 0328796 D0 GB0328796 D0 GB 0328796D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- interact
- compounds
- coupled receptor
- protein coupled
- receptor family
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0328796.8A GB0328796D0 (en) | 2003-12-12 | 2003-12-12 | Compounds which interact with the G-protein coupled receptor family |
PCT/GB2004/005169 WO2005056532A1 (en) | 2003-12-12 | 2004-12-10 | Indazole derivatives which interact with the g-protein coupled receptor family |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0328796.8A GB0328796D0 (en) | 2003-12-12 | 2003-12-12 | Compounds which interact with the G-protein coupled receptor family |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0328796D0 true GB0328796D0 (en) | 2004-01-14 |
Family
ID=30130085
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0328796.8A Ceased GB0328796D0 (en) | 2003-12-12 | 2003-12-12 | Compounds which interact with the G-protein coupled receptor family |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0328796D0 (en) |
WO (1) | WO2005056532A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8106070B2 (en) | 2006-10-20 | 2012-01-31 | Merck Sharp & Dohme Corp. | Substituted imidazoles as bombesin receptor subtype-3 modulators |
EP2091937A2 (en) | 2006-10-20 | 2009-08-26 | Merck & Co., Inc. | Substituted imidazoles as bombesin receptor subtype-3 modulators |
EP2083623A1 (en) | 2006-10-20 | 2009-08-05 | Merck & Co., Inc. | Substituted imidazoles as bombesin receptor subtype-3 modulators |
KR100832747B1 (en) | 2006-10-27 | 2008-05-27 | 한국화학연구원 | Aminopyrazole derivatives, process for the preparation thereof, and composition for preventing or treating an ischemic disease containing the same |
US7858645B2 (en) * | 2006-11-01 | 2010-12-28 | Hoffmann-La Roche Inc. | Indazole derivatives |
EP2102201B1 (en) * | 2006-12-11 | 2010-10-13 | Merck Sharp & Dohme Corp. | Substituted diazepine sulfonamides as bombesin receptor subtype-3 modulators |
US20110038850A1 (en) * | 2007-01-05 | 2011-02-17 | Didier Bagnol | G Protein-Coupled Receptor and Modulators Thereof For The Treatment of Gaba-Related Neurological Disorders Including Sleep-Related Disorders |
KR20100015499A (en) * | 2007-04-13 | 2010-02-12 | 노파르티스 아게 | Pyridazine-, pyridine- and pyrane-derivatives as gpbar1 agonists |
HUE040489T2 (en) | 2014-06-03 | 2019-03-28 | Idorsia Pharmaceuticals Ltd | Pyrazole compounds and their use as t-type calcium channel blockers |
EA032873B1 (en) | 2014-09-15 | 2019-07-31 | Идорсиа Фармасьютиклз Лтд | Triazole compounds as t-type calcium channel blockers |
MA49114A (en) | 2016-12-16 | 2020-03-25 | Idorsia Pharmaceuticals Ltd | PHARMACEUTICAL COMBINATION INCLUDING A T-TYPE CALCIUM CHANNEL BLOCKER |
EP3577099B1 (en) | 2017-02-06 | 2024-01-24 | Idorsia Pharmaceuticals Ltd | A novel process for the synthesis of 1-aryl-1-trifluoromethylcyclopropanes |
CN111205227A (en) * | 2018-11-22 | 2020-05-29 | 四川大学 | 3-vinyl indazole derivative and preparation method and application thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3725431A (en) * | 1970-09-23 | 1973-04-03 | Ciba Geigy Corp | 1-aralkyl-3-aminoindazoles |
EP1501800A1 (en) * | 2002-05-03 | 2005-02-02 | Warner-Lambert Company LLC | Bombesin antagonists |
DE10224844A1 (en) * | 2002-06-05 | 2004-01-08 | Solvay Pharmaceuticals Gmbh | Non-peptide BRS-3 agonists |
-
2003
- 2003-12-12 GB GBGB0328796.8A patent/GB0328796D0/en not_active Ceased
-
2004
- 2004-12-10 WO PCT/GB2004/005169 patent/WO2005056532A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2005056532A1 (en) | 2005-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0509275D0 (en) | Synthetic receptor | |
IL190094A0 (en) | Amino-alkyl-amide derivatives as ccr3 receptor liquids | |
GB0328796D0 (en) | Compounds which interact with the G-protein coupled receptor family | |
GB0509276D0 (en) | Synthetic receptor | |
EP1631559A4 (en) | Il-8 receptor antagonists | |
GB0403578D0 (en) | Compounds which interact with the G-protein coupled receptor family | |
EP1701948A4 (en) | Assay for entactogens | |
IL173337A0 (en) | Receptor | |
EP1991911A4 (en) | Plasticized photoconductor | |
IL174197A0 (en) | Chimeric gabab receptor | |
GB2420624B (en) | Sonde attachment means | |
GB0306522D0 (en) | Fastening mechanism | |
PL370290A1 (en) | Polyolephin based thermoplastics compound | |
GB0414798D0 (en) | Receptor | |
GB0504066D0 (en) | Compounds which interact with the g-protein coupled receptor family | |
GB0516946D0 (en) | Receptor | |
GB0321998D0 (en) | Receptor | |
GB0425739D0 (en) | Humanised baculovirus 2 | |
GB0510138D0 (en) | Novel compounds A4 | |
GB0413872D0 (en) | Receptor | |
GB0307100D0 (en) | Receptor | |
GB0329104D0 (en) | Receptor | |
GB0317346D0 (en) | 5-ht2b receptor antagonists | |
GB0320275D0 (en) | Skill-ball mechanism | |
EP1701949A4 (en) | Assay for entactogens |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |